Peptide nucleic acid chip for detecting muatatonal site of hepatitis B virus and its preparing method

A hepatitis B virus, mutation site technology, applied in the field of gene chips

CN1431318AInactive Publication Date: 2003-07-23SHANDONG MEDICAL BIO TECH RES CENT
0 Cites 2 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2003-07-23
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

A peptide nucleic acid chip for detecting the mutation sites of hepatitis B virus is composed of glass substrate or nylon film, peptide nucleic acid probes array and reference point-type coated layer. Its preparing process includes PCR amplification of hepatitis B virus DNA speciment, fluorescence labelling, and hybridization. The mutation sites can be determined according to the intensity of hybrid signals. Its advantages are high speed, high effect, and high correctness.
Need to check novelty before this filing date? Find Prior Art

Description

(1) Technical field

[0001] The invention relates to the field of gene chips, in particular to a peptide nucleic acid low-density chip and a preparation method thereof, in particular to a peptide nucleic acid detection chip for mutation sites of hepatitis B and a preparation method thereof. (2) Background technology

[0002] Gene chip technology was first developed based on the requirements of high-throughput and parallel analysis. It is mainly divided into expression profile chips and oligonucleotide chips. Oligonucleotide chips have potential advantages in clinical diagnosis, disease drug resistance detection, genotyping, etc., such as the study of human mitochondrial 16.6kb genome polymorphism, BRCAI exon 11, CFTR gene, ATM gene, HIV -1 Mutation detection of reverse transcriptase and protease genes, identification of different species within the genus Mycobacteria, and detection of rifazyme resistance, etc. In view of the advantages of gene chips requiring fewer samples ...

Examples

Embodiment 1

[0047] Embodiment 1: structure as attached figure 1 Shown:

[0048] Peptide nucleic acid probes and control point coating 2 are evenly distributed in an array on the substrate 1, which contains 24 detection probes of known mutation sites and wild sites in the pre-C and S regions of hepatitis B, and 2 are positive Control probe, 1 negative control probe and blank sample solution control. Positive probes are located around the array, which not only serves as a positive control, but also serves as a positive signal to locate the array. The PCR amplified product of the hepatitis B DNA sample is labeled by in vitro transcription and hybridized with the peptide nucleic acid array, and the result is obtained by scanning with a laser confocal scanner, and analyzed and judged.

Embodiment 2

[0049] Example 2: Modification of slides and fixation of peptide nucleic acid probes

[0050] 1. Modification of slides

[0051] The blank glass slide was washed with 10% NaOH, then washed with 1% HCI acid solution, washed with water and then dried to obtain a clean glass bare chip. Treat with 95% acetone solution of 1% 3-aminopropyltrimethoxysilane for 30 minutes, then wash with acetone for 3 times, 5 minutes each time, and bake at 80°C for 15 minutes to obtain the aminated glass slide. Continue to treat with 10% glutaraldehyde aqueous solution for 30 minutes, then wash with double distilled water, and obtain an aldylation-modified glass slide after vacuum drying.

[0052] 2. Immobilization of peptide nucleic acid probes (take the formaldehyde slide as an example)

[0053] The design and selection of peptide nucleic acid probes are shown in Table 1.

[0054] Immobilization of peptide nucleic acid probes on aldylated slides with saturated NaHCO 3 solution as the sample sol...

Embodiment 3

[0061] Example 3: Extraction, PCR amplification and labeling of hepatitis B sample DNA

[0062] 1. Extraction of DNA from hepatitis B samples

[0063] 1) Take 100 μl of hepatitis B serum, add 3 times the volume of lysate (4M guanidine thiocyanate, mercaptoethanol, 0.1M Tris-CI, pH7.5), and mix well.

[0064] 2) Add an equal volume of chloroform and isoamyl alcohol solution (24:1), and mix well. Centrifuge at 12,000 rpm for 15 minutes at room temperature.

[0065] 3) Carefully transfer the supernatant into another 1.5ml centrifuge tube, and add 2 times the volume of absolute ethanol. Store at -20°C for 2 hours. Centrifuge at 12000 rpm for 15 minutes at 4°C.

[0066] 4) The precipitate obtained after centrifugation was washed twice with 70% ethanol, and centrifuged at 12000 rpm for 10 minutes at 4° C. each time.

[0067] 5) The precipitate was naturally dried and dissolved in 16 μl of pure water.

[0068] 2. Amplification and purification of PCR target fragment

[0069] 1...